logo

For the Inventor, By the Inventor

Madison, CT, United States of America

Zhongxing Zhang

This inventor holds 65 USPTO granted patents and 34 published patent applications and 42 EPO patents, primarily in Antiviral Compounds (CPC class C07D). Top assignees: Bristol-Myers Squibb Compnay, Viiv Healthcare UK (No.5) Limited, Bristol Meyers Squibb Company. Active years: 2002-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zhongxing Zhang. Retrieved from https://idiyas.com/inventor/zhongxing-zhang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 65 

% Patents Active = 73.8

 

Average Co-Inventor Count = 5.8

ph-index = 11

Forward Citations = 432(Granted Patents)

Forward Citations (Not Self Cited) = 263(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Madison, CT (US) (2002 - 2019)
  • Wallingford, CT (US) (2017 - 2022)

Company Filing History:

goldMedal54 out of 3,742 
 
Bristol-Myers Squibb Compnay
 patents
silverMedal8 out of 45 
 
Viiv Healthcare UK (No.5) Limited
 patents
bronzeMedal2 out of 41 
 
Bristol Meyers Squibb Company
 patents
4. 1 out of 8 
 
Viiv Healthcare UK (No. 4) Limited
 patents

Years Active: 2002-2026

Loading Chart...
Loading Chart...
Areas of Expertise:
Immunomodulators
Antiviral Agents
Hepatitis C
HIV Replication
Pyridin Derivatives
Benzofuran Compounds
Macrocyclic Compounds
Tricyclic Derivatives
Fused Bicyclic Compounds
Prodrugs
Piperazine
Azaindole Derivatives
65 patents (USPTO):Explore Patents
1. 12723041 - Lactone and lactam containing compounds useful as immunomodulators (2026-09-01),
2. 12403174 - Immunomodulators (2025-09-02),
3. 11369624 - Salts of prodrugs of piperazine and substituted piperidine antiviral agents (2022-06-28),
4. 10577353 - 5-(n-[6,5]-fused bicyclic aryl tetrahydroisoquinolin-6-yl) pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication (2020-03-03),
5. 10407410 - Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication (2019-09-10),
6. 10214534 - Substituted 2-phenyl (AZA)benzofuran compounds for the treatment of hepatitis C (2019-02-26),
7. 10214516 - 5-(N-fused tricyclic aryl tetrahydroisoquinolin-6-yl) pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication (2019-02-26),
8. 10202403 - Macrocyclic benzofuran compounds for the treatment of hepatitis C (2019-02-12),
9. 10189816 - Substituted pyridines as inhibitors of human immunodeficiency virus replication (2019-01-29),
10. 10144706 - Compounds useful as immunomodulators (2018-12-04),
11. 10125111 - Benzofuran compounds for the treatment of hepatitis C (2018-11-13),
12. 9957278 - Furopyridine compounds for the treatment of hepatitis C (2018-05-01),
13. 9918988 - Ammonium derivatives for the treatment of hepatitis C (2018-03-20),
14. 9914739 - 6H-furo[2,3-E]indole compounds for the treatment of hepatitis C (2018-03-13),
15. 9868743 - Macrocyclic molecules as HCV entry inhibitors (2018-01-16),

Title: Innovator Spotlight: Zhongxing Zhang

Introduction:

Meet Zhongxing Zhang, a prolific inventor based in Madison, CT, US, with an impressive track record of 63 patents to his name. His groundbreaking inventions in the field of pharmaceuticals, specifically in the treatment of HIV infection, have made a significant impact on the medical industry.

Latest Patents:

One of his latest patents includes the development of "Salts of prodrugs of piperazine and substituted piperidine antiviral agents." This innovation introduces prodrug Compounds I and intermediate Compounds II for treating HIV infection. Additionally, Zhang's invention of "5-(n-[6,5]-fused bicyclic aryl tetrahydroisoquinolin-6-yl) pyridin-3-yl acetic acid derivatives" as inhibitors of HIV replication showcases his commitment to advancing antiviral therapies.

Career Highlights:

Zhongxing Zhang has a rich professional background, having contributed his expertise to renowned companies such as Bristol-Myers Squibb Company and ViiV Healthcare UK Limited. His passion for pharmaceutical research and development has led to significant advancements in the field of antiviral medications.

Collaborations:

Throughout his career, Zhang has collaborated closely with industry experts, including his coworkers Tao Wang and John F. Kadow. These collaborations have been instrumental in the success of his patented inventions and have further solidified his reputation as a key player in the pharmaceutical innovation landscape.

Conclusion:

In conclusion, Zhongxing Zhang stands out as a dedicated inventor whose contributions have transformed the landscape of HIV treatment. His innovative patents and collaborations have not only enriched the field of pharmaceuticals but have also offered new hope to those affected by HIV and AIDS. Zhang's relentless pursuit of excellence continues to inspire future generations of inventors in the quest for medical breakthroughs.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…